Annals of Internal Medicine · 1982 · 486 citations · 24 references
MedicineOncologyPharmacologyChemotherapyMedical OncologyPharmacokinetics Of Anticancer AgentsChemotherapy Toxicity ManagementMalignant NeoplasmsNephrotoxicity ManagementRenal ProtectionSolid Tumor OncologyToxicity ManagementArea Under The Plasma Concentration-time CurveBody Surface Area - Based DosingChemotherapy-associated NephrotoxicityPeritoneal MesotheliomaPlatinum-based Chemotherapy Renal ToxicityPlatinum-based RegimensSodium Thiosulfate TherapySystemic Therapy Toxicity
Seventeen patients with intraperitoneal tumors were treated by 4-hour intraperitoneal dialysis with cisplatin alone, or in combination with an intravenous neutralizing agent, sodium thiosulfate. Cisplatin alone, 90 mg/m2 body surface area intraperitoneally, produced nephrotoxicity. When intraperitoneal cisplatin therapy was combined with intravenous thiosulfate treatment, the dose of cisplatin could be escalated to 270 mg/m2 body surface area without causing an increase in serum creatinine levels or undue myelosuppression. Even at doses up to 270 mg/m2, no local toxicity occurred. The peak peritoneal concentration of free reactive cisplatin averaged 21-fold higher than the plasma level, and the area under the peritoneal cisplatin elimination curve averaged 12-fold more than the area under the plasma curve. Neither of these ratios varied significantly with cisplatin dose. Regression of intraperitoneal tumor masses was observed in patients with far-advanced ovarian carcinoma, mesothelioma, and malignant carcinoid.
24
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
Dedrick Rl, Myers Ce, Bungay Pm et al. · PubMed · 1978 · 743 citations
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
Von Hoff, Richard L. Schilsky, Reichert Cm et al. · PubMed · 1980 · 338 citations
Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.
Robert F. Ozols, Gershon Y. Locker, James H. Doroshow et al. · PubMed · 1979 · 248 citations
Medicine, Oncology, Pharmacology +13